TrialBMC psychiatry2016

Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability.

Giulia Malaguarnera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.